Marko Mychaskiw - Teva Pharmaceutical Industries Ltd.

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Responding to Correspondence on "clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes"

Leslie Citrome,Marko A Mychaskiw, Alma Cortez,Mark Opler, Liza Sopina,Sameer Kotak

PubMedno. 4-6 (2024): 8-9

引用0浏览0WOS引用

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia

Leslie Citrome,Mark Suett, Kelli R Franzenburg, Roy Eshet, Anna Elgart, Glen L Davis Rd, Eran Harary, Orna Tohami,Marko A Mychaskiw,John M Kane

Neuropsychiatric disease and treatment (2024): 1901-1917

引用0浏览0WOS引用

Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia

John M Kane,Marko A Mychaskiw,Sangtaeck Lim,Mark Suett,Marc Tian,Jose M Rubio

The Journal of clinical psychiatry（2023）

引用0浏览0WOS引用

It alt --lst this c PDF on any website. Treatment journey rom Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia

John M. Kane,Marko A. Mychaskiw,Sangtaeck Lim,Mark Suett,Marc Tian,Jose M. Rubio

JOURNAL OF CLINICAL PSYCHIATRYno. 3 (2023)

引用0浏览0引用

Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals with Early-Phase Schizophrenia

Jose M. Rubio,Marko A. Mychaskiw,Sangtaeck Lim,Mark Suett,Yitong Wang,Marc Tian,John M. Kane

The Journal of Clinical Psychiatry（2023）

引用1浏览0WOS引用

Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia

Delbert G. Robinson,Mark Suett,Amanda Wilhelm,Nayla Chaijale,Kelli R. Franzenburg,Sanjay Gandhi,Blaine Cloud,Marko Mychaskiw

Advances in therapyno. 5 (2023): 2249-2264

引用0浏览0WOS引用

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database

John M. Kane, Anna Chen,Sangtaeck Lim,Marko A. Mychaskiw,Marc Tian,Yitong Wang,Mark Suett,Jose M. Rubio

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY（2023）

引用2浏览0WOS引用

Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians

Leslie Citrome,Emily Belcher,Sylvie Stacy,Mark Suett,Marko Mychaskiw,Gregory D. Salinas

NEUROPSYCHIATRIC DISEASE AND TREATMENT（2022）

引用10浏览0WOS引用

Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study

Leslie Citrome,Emily Belcher,Sylvie Stacy,Mark Suett,Marko Mychaskiw,Gregory D. Salinas

PATIENT PREFERENCE AND ADHERENCE（2022）

引用6浏览0WOS引用

Atypical Antipsychotic Agent Use From Diagnosis to Long-Acting Injectable Antipsychotic Agent Implementation Among Patients With Schizophrenia in the United States: An Analysis of a Commercial Claims Database

John Kane,Marko Mychaskiw,Sangtaeck Lim,Mark Suett,Marc Tian, Seojin Park,Jose Rubio

NEUROPSYCHOPHARMACOLOGY（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn